Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00605956 · ClinicalTrials.gov registry record · Phase 1
NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers
A Phase 1 study, sponsored by ParaPRO.
- Completed
- Registry status
- Phase 1
- Development phase
- 65
- Enrollment target
NCT00605956 is a Phase 1 study that has completed, run by ParaPRO. The registered enrollment target is 65 participants.
The verdict
NCT00605956, a Phase 1 study, has completed, sponsored by ParaPRO.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 65 participants
- Enrollment target
Study Summary
Photoallergic reactions are assumed to be due to a delayed cell-mediated hypersensitivity response that requires the presence of ultraviolet irradiation. The predictive procedure is, therefore, based on modification of the Repeated Insult Patch Test (Kaidbey, 1991). Duplicate sets of patches of test articles are used with exposure of only one set to UV radiation and subsequent evaluation of both sets for skin reactions in order to compare irradiated versus non-irradiated test sites.
Interventions
- DRUG NatrOVA Creme Rinse - 1%
- DRUG NatrOVA Creme Rinse Vehicle Only
- DRUG Blank Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00605956
The ClinicalTrials.gov registry entry for NCT00605956 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ParaPRO, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which NatrOVA Creme Rinse - 1% is the first listed.
NCT00605956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00605956 about?
NCT00605956 is a clinical study titled "NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers". Photoallergic reactions are assumed to be due to a delayed cell-mediated hypersensitivity response that requires the presence of ultraviolet irradiation. The predictive procedure is, therefore, based on modification of the Repeated Insult Patch Test (Kaidbey, 1991). Duplicate sets of patches of test...
What is the current status of trial NCT00605956?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2008-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00605956?
The interventions under investigation include: NatrOVA Creme Rinse - 1% (DRUG), NatrOVA Creme Rinse Vehicle Only (DRUG), Blank Patch (DRUG).
Who is sponsoring clinical trial NCT00605956?
This trial is sponsored by ParaPRO, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.